MRNA | Complete Moderna Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
A high-level overview of Moderna, Inc. (MRNA) stock. View (MRNA) real-time stock price, chart, news, analysis, analyst reviews and more.
Moderna price target lowered to $25 from $35 at Wolfe Research11 Hours AgoTipRanks Moderna says norovirus vaccine trial on FDA clinical hold11 Hours AgoTipRanks Ray Dalio’s Bridgewater Opened a New Position in Tesla Stock (TSLA)12 Hours AgoTipRanks Airbnb, Moderna report Q4 results: Morning...
Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker | MRNAU.S.: Nasdaq +Watchlist You must be logged in to create alerts Open Last Updated:Feb 24, 2025 1:43 p.m.ESTReal time quote $34.43 -1.10-3.10% Previous Close $35.53 ...
Skip NavigationMarkets Business Investing Tech Politics Video Investing Club PRO
Moderna Stock Forecast, MRNA stock price prediction. Price target in 14 days: 43.523 USD. The best long-term & short-term Moderna share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily MRNA exchange price projections: monthly and daily o
Price (USD)0.0453 Today's Change0.002 / 4.02% Shares traded467.16k 1 Year change-99.41% Data delayed at least 20 minutes, as of Feb 13 2025 16:28 GMT. Find Funds and ETFs Use our fund screener to discover other asset types. Go to the Funds Screener ...
Price (EUR)0.775 Today's Change-0.015 / -1.90% Shares traded-- 1 Year change-- Beta-- Data delayed at least 15 minutes, as of Jan 29 2025 18:30 GMT. Participate in the 2025 Stockpicking Contest Long or short five stocks and compete to have the highest return by the end of the ye...
Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new January 2025 contracts and ident
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Moderna shares have lost about 47.9% since the beginning of the year versus the S&P 500's gain of...